Gritstone Bio Inc has a consensus price target of $5.8, established from looking at the 14 latest analyst ratings. The last 3 analyst ratings were released from JMP Securities, HC Wainwright & Co., and JMP Securities on April 2, 2024, March 6, 2024, and February 28, 2024. With an average price target of $5.33 between JMP Securities, HC Wainwright & Co., and JMP Securities, there's an implied 611.11% upside for Gritstone Bio Inc from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
04/02/2024 | GRTS | Buy Now | Gritstone Bio | $0.75 | 566.67% | JMP Securities | Roy Buchanan | $4 → $5 | Maintains | Market Outperform | Get Alert |
03/06/2024 | GRTS | Buy Now | Gritstone Bio | $0.75 | 833.33% | HC Wainwright & Co. | Sean Lee | → $7 | Reiterates | Buy → Buy | Get Alert |
02/28/2024 | GRTS | Buy Now | Gritstone Bio | $0.75 | 433.33% | JMP Securities | Roy Buchanan | → $4 | Initiates | → Market Outperform | Get Alert |
09/28/2023 | GRTS | Buy Now | Gritstone Bio | $0.75 | 833.33% | Piper Sandler | Edward Tenthoff | $6 → $7 | Maintains | Overweight | Get Alert |
08/10/2023 | GRTS | Buy Now | Gritstone Bio | $0.75 | 833.33% | HC Wainwright & Co. | Sean Lee | → $7 | Reiterates | Buy → Buy | Get Alert |
05/15/2023 | GRTS | Buy Now | Gritstone Bio | $0.75 | 833.33% | HC Wainwright & Co. | Sean Lee | → $7 | Reiterates | Buy → Buy | Get Alert |
03/28/2023 | GRTS | Buy Now | Gritstone Bio | $0.75 | 966.67% | B. Riley Securities | Mayank Mamtani | → $8 | Initiates | → Buy | Get Alert |
03/14/2023 | GRTS | Buy Now | Gritstone Bio | $0.75 | 833.33% | HC Wainwright & Co. | Sean Lee | → $7 | Reiterates | → Buy | Get Alert |
02/15/2023 | GRTS | Buy Now | Gritstone Bio | $0.75 | 833.33% | HC Wainwright & Co. | Sean Lee | → $7 | Maintains | Buy | Get Alert |
11/07/2022 | GRTS | Buy Now | Gritstone Bio | $0.75 | 833.33% | HC Wainwright & Co. | Sean Lee | $12 → $7 | Maintains | Buy | Get Alert |
10/31/2022 | GRTS | Buy Now | Gritstone Bio | $0.75 | 700% | Piper Sandler | Edward Tenthoff | → $6 | Initiates | → Overweight | Get Alert |
08/22/2022 | GRTS | Buy Now | Gritstone Bio | $0.75 | 166.67% | Goldman Sachs | Corinne Jenkins | → $2 | Downgrade | Neutral → Sell | Get Alert |
05/09/2022 | GRTS | Buy Now | Gritstone Bio | $0.75 | 1500% | HC Wainwright & Co. | Sean Lee | $15 → $12 | Maintains | Buy | Get Alert |
03/14/2022 | GRTS | Buy Now | Gritstone Bio | $0.75 | 1900% | HC Wainwright & Co. | Sean Lee | $24 → $15 | Maintains | Buy | Get Alert |
The latest price target for Gritstone Bio (NASDAQ: GRTS) was reported by JMP Securities on April 2, 2024. The analyst firm set a price target for $5.00 expecting GRTS to rise to within 12 months (a possible 566.67% upside). 6 analyst firms have reported ratings in the last year.
The latest analyst rating for Gritstone Bio (NASDAQ: GRTS) was provided by JMP Securities, and Gritstone Bio maintained their market outperform rating.
There is no last upgrade for Gritstone Bio.
The last downgrade for Gritstone Bio Inc happened on August 22, 2022 when Goldman Sachs changed their price target from N/A to $2 for Gritstone Bio Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Gritstone Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Gritstone Bio was filed on April 2, 2024 so you should expect the next rating to be made available sometime around April 2, 2025.
While ratings are subjective and will change, the latest Gritstone Bio (GRTS) rating was a maintained with a price target of $4.00 to $5.00. The current price Gritstone Bio (GRTS) is trading at is $0.75, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.